Helen Barnacle

896 total citations
12 papers, 663 citations indexed

About

Helen Barnacle is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Helen Barnacle has authored 12 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 0 papers in Infectious Diseases. Recurrent topics in Helen Barnacle's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (8 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Helen Barnacle is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (8 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Helen Barnacle collaborates with scholars based in United Kingdom, United States and Denmark. Helen Barnacle's co-authors include David A. Lipson, David A. Lomas, Noushin Brealey, Rajat Mohindra, Steven Pascoe, Nicholas Locantore, Ruby Birk, Chang‐Qing Zhu, Markku M. Nieminen and Maggie Tabberer and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Helen Barnacle

12 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Barnacle United Kingdom 8 556 465 54 33 31 12 663
J. F. Costello United Kingdom 11 187 0.3× 167 0.4× 64 1.2× 53 1.6× 29 0.9× 14 396
Stephanie Harris United States 7 625 1.1× 573 1.2× 36 0.7× 4 0.1× 13 0.4× 17 781
M. Brenner United States 7 136 0.2× 185 0.4× 33 0.6× 20 0.6× 63 2.0× 10 325
Sümeyye Alparslan Bekir Türkiye 5 223 0.4× 248 0.5× 58 1.1× 18 0.5× 27 0.9× 14 352
Yoshihisa Ishiura Japan 13 248 0.4× 290 0.6× 67 1.2× 28 0.8× 6 0.2× 37 413
Chris Tucker United States 8 80 0.1× 148 0.3× 41 0.8× 57 1.7× 15 0.5× 10 395
Grazyna Pinis Poland 4 219 0.4× 350 0.8× 30 0.6× 12 0.4× 16 0.5× 8 422
Divya Chhabra United States 12 115 0.2× 86 0.2× 157 2.9× 12 0.4× 69 2.2× 18 392
Peter Teichmann Italy 4 231 0.4× 183 0.4× 131 2.4× 10 0.3× 4 0.1× 5 363
Jiayan Xu China 4 198 0.4× 85 0.2× 82 1.5× 21 0.6× 4 0.1× 7 316

Countries citing papers authored by Helen Barnacle

Since Specialization
Citations

This map shows the geographic impact of Helen Barnacle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Barnacle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Barnacle more than expected).

Fields of papers citing papers by Helen Barnacle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Barnacle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Barnacle. The network helps show where Helen Barnacle may publish in the future.

Co-authorship network of co-authors of Helen Barnacle

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Barnacle. A scholar is included among the top collaborators of Helen Barnacle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Barnacle. Helen Barnacle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mehta, Rashmi, Misba Beerahee, Noushin Brealey, et al.. (2018). Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD. The Journal of Clinical Pharmacology. 58(11). 1461–1467. 3 indexed citations
2.
Lipson, David A., Helen Barnacle, Ruby Birk, et al.. (2017). FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 196(4). 438–446. 226 indexed citations
3.
Naya, Ian, Helen Barnacle, Ruby Birk, et al.. (2017). Clinically important deterioration in advanced COPD patients using single inhaler triple therapy: results from the FULFIL study. PA3248–PA3248. 3 indexed citations
4.
Lipson, David A., Helen Barnacle, Ruby Birk, et al.. (2017). Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses. PA1057–PA1057. 2 indexed citations
5.
Pascoe, Steven, David A. Lipson, Nicholas Locantore, et al.. (2016). A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol. European Respiratory Journal. 48(2). 320–330. 60 indexed citations
6.
Lomas, David A., David A. Lipson, Helen Barnacle, et al.. (2016). LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial. PA4629–PA4629. 1 indexed citations
7.
Watz, Henrik, Helen Barnacle, Benjamin Hartley, & Robert Chan. (2013). Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine. 2(1). 63–72. 71 indexed citations
8.
Lomas, David A., David A. Lipson, Bruce E. Miller, et al.. (2011). An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease. The Journal of Clinical Pharmacology. 52(3). 416–424. 91 indexed citations
9.
Price, Jack, et al.. (2002). HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma. Respiratory Medicine. 96(8). 625–631. 9 indexed citations
10.
Manjra, A I, Jack Price, Warren Lenney, Scott Hughes, & Helen Barnacle. (2000). Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respiratory Medicine. 94(12). 1206–1214. 37 indexed citations
11.
Saarelainen, Sami, et al.. (1999). Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respiratory Medicine. 93(10). 689–699. 15 indexed citations
12.
Dahl, Ronald E., Bo Lundbäck, Jean-Luc Malo, et al.. (1993). A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma. CHEST Journal. 104(5). 1352–1358. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026